Sign in
CompletedNo phase

An Innovative Conversational Agent (Quitbot) for Smoking Cessation

Key facts

Who runs it
Fred Hutchinson Cancer Center
Where
Seattle, United StatesSee the site
Trial code
Status
Completed
People taking part
1,647 people enrolled
Started
24 Jul 2022
Ended
8 Apr 2026
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Experimental Smoking Cessation Program
  • Control Smoking Cessation Program
Record updated
22 May 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Can take part
Show the full registry criteria (12)Hide the full registry criteria

Who can take part

  • Age 18 or older
  • Smokes at least one cigarette a day for the past 12 months
  • Wants to quit cigarette smoking within the next 30 days (consistent with text messaging intervention trials)
  • If concurrently using any other nicotine or tobacco products, wants to quit using them within the next 30 days
  • Interested in learning skills to quit smoking
  • Willing to be randomly assigned to either intervention
  • Resides in United States (US) and will continue to reside in the US for the next 12 months
  • Has at least daily access to their own smartphone
  • Has text messaging on their smartphone and knows how to download a smartphone application
  • Willing and able to read in English, and
  • Not using other smoking cessation interventions (This eligibility requirement helps ensure results are due to the treatments we recommend rather than those that participants are doing on their own.)

Who cannot take part

  • The reverse of the inclusion criteria

Where in United States

  • Fred Hutch/University of Washington Cancer ConsortiumSeattle, United States

About the trial

What the trial wants to find out

This phase III trial compares two remote digital smoking cessation programs to see how well they work for quitting smoking.

The 2 groups in the trial

  • Group I (QuitBot Experimental)Treatment being tested

    Participants participate in the QuitBot program for 42 days to support quitting smoking. QuitBot is a novel chatbot smartphone application for smoking cessation.

    Treatment: Experimental Smoking Cessation Program

  • Group II (SmokefreeTXT Control)Existing treatment, for comparison

    Participants participate in the SmokefreeTXT program for 42 days to support quitting smoking. SmokefreeTXT is a standard of care smoking cessation text messaging program from the NCI.

    Treatment: Control Smoking Cessation Program

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Full Scale Randomized Trial of an Innovative Conversational Agent for Smoking Cessation (QuitBot)
Publications
Record updated
22 May 2026